Drugs / AER 001
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00785668 | Nov 2007 → Feb 2008 | asthma | Aerovance, Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00535431 | Dec 2005 → Oct 2006 | allergic asthma | Aerovance, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AER 001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00785668 ↗ |
| Route | Other | “Treatments will be administered by nebulization from a PARI LC Plus nebulizer” NCT00535431 ↗ |